30 Covid-19 vaccines in different stages of development: Scientists to PM Modi

Updated on May 06, 2020 10:54 AM IST
Prime Minister Modi on Tuesday chaired a meeting of the task force on coronavirus vaccine development and took a detailed review of the current status of India’s steady efforts in vaccine development
Prime Minister Narendra Modi has enquired about the stages in which India’s vaccine development is currently at.(ANI Photo)
Prime Minister Narendra Modi has enquired about the stages in which India’s vaccine development is currently at.(ANI Photo)
Hindustan Times, New Delhi | ByHindustantimes.com | Edited by: Meenakshi Ray

More than 30 vaccines against the coronavirus disease (Covid-19) are in different stages of development and a few are going to trial stages in India even as existing drugs are being repurposed, experts have informed Prime Minister Narendra Modi during a meeting of the task force.

Prime Minister Modi on Tuesday chaired a meeting of the task force on coronavirus vaccine development and took a detailed review of the current status of India’s steady efforts in vaccine development, drug discovery, diagnosis and testing.

According to a statement released by the Prime Minister’s office after the meeting, Indian companies have come across as innovators in early-stage vaccine development research.

The statement said that three approaches are being taken in drug development in the country.

“First, the repurposing of existing drugs. At least four drugs are undergoing synthesis and examination in this category,” the statement said.

“Secondly, the development of new candidate drugs and molecules are being driven by linking high performance computational approached with laboratory verification. Thirdly, plant extracts and products are being examined for general anti-viral properties,” it added.

Several academic research institutions and start-ups have developed new tests, both for the Reverse transcription-polymerase chain reaction (RT-PCR) approach and for antibody detection, in diagnosis and testing. Capacity for both these tests has been enormously scaled up by linking laboratories across the country.

“The problem of importing reagents for testing has been addressed by consortia of Indian start-ups and industry, meeting current requirements. The current thrust also holds promise for the development of a robust long-term industry in this area,” the statement said.

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, August 15, 2022
Start 15 Days Free Trial Subscribe Now